Showing results (21-30 of 342) with videos related to
Sort By:
Pageof 35
Mediterranean Journal of Hematology and Infectious Diseases|June 25, 2014
Immunological deregulation in classic hodgkin lymphomaAlessandra Romano, Calogero Vetro, Giovanni Caocci, et al.Frontiers in Oncology|July 26, 2021
Mechanisms of Action of the New Antibodies in Use in Multiple MyelomaAlessandra Romano, Paola Storti, Valentina Marchica, et al.Hematology, Transfusion and Cell Therapy|September 17, 2023
Evaluation of erythrocytapheresis compared to phlebotomy in polycythaemia vera patientsSergio Cabibbo, Giovanna Oriella Manenti, Agostino Antolino, et al.Current Hematologic Malignancy Reports|April 29, 2010
Treatment of newly diagnosed multiple myelomaAntonio Palumbo, Valeria Magarotto, Alessandra Larocca, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 23, 2022
Acquired hemophilia A following COVID-19 vaccination - The importance of prompt diagnosis: A case reportAndrea Duminuco, Marianna Calagna, Uros Markovic, et al.Biomolecules|January 25, 2025
Comprehensive Analysis of TSPAN32 Regulatory Networks and Their Role in Immune Cell BiologyGrazia Scuderi, Katia Mangano, Maria Cristina Petralia, et al.Frontiers in Oncology|September 29, 2022
Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myelomaMatteo Trudu, Laura Oliva, Ugo Orfanelli, et al.Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology|March 11, 2009
Aberrant phenotypic expression of the T-cell-associated antigen CD8 on B-cell chronic lymphocytic leukemia cellsFabio Stagno, Anna Triolo, Vittorio Del Fabro, et al.Leukemia & Lymphoma|March 5, 2003
Alternation of epirubicin and mitoxantrone in CHOP-like regimens retains efficacy and reduces overall toxicity in elderly patients with high and intermediate grade non-Hodgkin lymphomasGiuseppe Milone, Francesco Di Raimondo, Felicina Li Gioi, et al.Journal of Clinical Medicine|December 23, 2022
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life SettingAndrea Duminuco, Antonella Nardo, Bruno Garibaldi, et al.Pageof 35